Novo Nordisk's Victoza fails type 1 diabetes trial Adding Novo Nordisk's Victoza to insulin therapy in type 1 diabetics worsened episodes of
Victoza (liraglutide) is a glucagon-like Victoza is not recommended for treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
Victoza should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Victoza is not a substitute for insulin.
Victoza should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Victoza is not a substitute for insulin.
Victoza should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Victoza is not a substitute for insulin.
VICTOZA is not a substitute for insulin. VICTOZA should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic
Novo Nordisk's Victoza fails type 1 diabetes trial Adding Novo Nordisk's Victoza to insulin therapy in type 1 diabetics worsened episodes of
Victoza is not a substitute for insulin. Victoza should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis
Victoza should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Victoza should not be
Comments
Oh, type 1 diabetes is controlled by insulin not pills.